Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention
Purpose: The change in coronary physiology from lipid-lowering therapy (LLT) lacks an appropriate method of examination. Quantitative flow ratio (QFR) is a novel angiography-based approach allowing rapid assessment of coronary physiology. This study sought to determine the impact of low-density lipo...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.679599/full |
id |
doaj-48f5fb3f9e7540d7b05c49b38997100f |
---|---|
record_format |
Article |
spelling |
doaj-48f5fb3f9e7540d7b05c49b38997100f2021-06-18T06:02:22ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-06-01810.3389/fcvm.2021.679599679599Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary InterventionLong Chen0Long Chen1Long Chen2Qin Chen3Qin Chen4Qin Chen5Jiaxin Zhong6Jiaxin Zhong7Jiaxin Zhong8Zhen Ye9Zhen Ye10Zhen Ye11Mingfang Ye12Mingfang Ye13Mingfang Ye14Yuanming Yan15Yuanming Yan16Yuanming Yan17Lianglong Chen18Lianglong Chen19Lianglong Chen20Yukun Luo21Yukun Luo22Yukun Luo23Department of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaPurpose: The change in coronary physiology from lipid-lowering therapy (LLT) lacks an appropriate method of examination. Quantitative flow ratio (QFR) is a novel angiography-based approach allowing rapid assessment of coronary physiology. This study sought to determine the impact of low-density lipoprotein cholesterol (LDL-C) goal achievement on coronary physiology through QFR.Methods: Cases involving percutaneous coronary intervention (PCI) and 1-year angiographic follow-up were screened and assessed by QFR analysis. Patients were divided into two groups according to the LDL-C level at the 1-year follow-up: (1) goal-achievement group (LDL-C < 1.8 mmol/L or reduction of ≥50%, n = 146, lesion = 165) and (2) non-achievement group (n = 286, lesion = 331). All QFR data and major adverse cardiovascular and cerebrovascular events (MACCEs) at 1 year were compared between groups.Results: No differences between the groups in quantitative coronary angiography (QCA) data or QFR post-PCI were found. At the 1-year follow-up, lower percentage diameter stenosis (DS%) and percentage area stenosis (AS%) were recorded in the goal-achievement group (27.89 ± 10.16 vs. 30.93 ± 12.03, p = 0.010, 36.57 ± 16.12 vs. 41.68 ± 17.39, p = 0.003, respectively). Additionally, a better change in QFR was found in the goal-achievement group (0.003 ± 0.068 vs. −0.018 ± 0.086, p = 0.007), with a lower incidence of physiological restenosis and MACCEs (2.1 vs. 8.4%, p = 0.018, 5.4 vs. 12.6%, p = 0.021, respectively).Conclusion: Evaluated by QFR, patients who achieved the LDL-C goal appear to have a better coronary physiological benefit. This group of patients also has a better clinical outcome.https://www.frontiersin.org/articles/10.3389/fcvm.2021.679599/fullpercutaneous coronary interventionLDL—cholesterolquantative flow ratiocornoray physiologyphysiological restenosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Long Chen Long Chen Long Chen Qin Chen Qin Chen Qin Chen Jiaxin Zhong Jiaxin Zhong Jiaxin Zhong Zhen Ye Zhen Ye Zhen Ye Mingfang Ye Mingfang Ye Mingfang Ye Yuanming Yan Yuanming Yan Yuanming Yan Lianglong Chen Lianglong Chen Lianglong Chen Yukun Luo Yukun Luo Yukun Luo |
spellingShingle |
Long Chen Long Chen Long Chen Qin Chen Qin Chen Qin Chen Jiaxin Zhong Jiaxin Zhong Jiaxin Zhong Zhen Ye Zhen Ye Zhen Ye Mingfang Ye Mingfang Ye Mingfang Ye Yuanming Yan Yuanming Yan Yuanming Yan Lianglong Chen Lianglong Chen Lianglong Chen Yukun Luo Yukun Luo Yukun Luo Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention Frontiers in Cardiovascular Medicine percutaneous coronary intervention LDL—cholesterol quantative flow ratio cornoray physiology physiological restenosis |
author_facet |
Long Chen Long Chen Long Chen Qin Chen Qin Chen Qin Chen Jiaxin Zhong Jiaxin Zhong Jiaxin Zhong Zhen Ye Zhen Ye Zhen Ye Mingfang Ye Mingfang Ye Mingfang Ye Yuanming Yan Yuanming Yan Yuanming Yan Lianglong Chen Lianglong Chen Lianglong Chen Yukun Luo Yukun Luo Yukun Luo |
author_sort |
Long Chen |
title |
Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention |
title_short |
Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention |
title_full |
Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention |
title_fullStr |
Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention |
title_full_unstemmed |
Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention |
title_sort |
effect of low-density lipoprotein cholesterol goal achievement on vascular physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Cardiovascular Medicine |
issn |
2297-055X |
publishDate |
2021-06-01 |
description |
Purpose: The change in coronary physiology from lipid-lowering therapy (LLT) lacks an appropriate method of examination. Quantitative flow ratio (QFR) is a novel angiography-based approach allowing rapid assessment of coronary physiology. This study sought to determine the impact of low-density lipoprotein cholesterol (LDL-C) goal achievement on coronary physiology through QFR.Methods: Cases involving percutaneous coronary intervention (PCI) and 1-year angiographic follow-up were screened and assessed by QFR analysis. Patients were divided into two groups according to the LDL-C level at the 1-year follow-up: (1) goal-achievement group (LDL-C < 1.8 mmol/L or reduction of ≥50%, n = 146, lesion = 165) and (2) non-achievement group (n = 286, lesion = 331). All QFR data and major adverse cardiovascular and cerebrovascular events (MACCEs) at 1 year were compared between groups.Results: No differences between the groups in quantitative coronary angiography (QCA) data or QFR post-PCI were found. At the 1-year follow-up, lower percentage diameter stenosis (DS%) and percentage area stenosis (AS%) were recorded in the goal-achievement group (27.89 ± 10.16 vs. 30.93 ± 12.03, p = 0.010, 36.57 ± 16.12 vs. 41.68 ± 17.39, p = 0.003, respectively). Additionally, a better change in QFR was found in the goal-achievement group (0.003 ± 0.068 vs. −0.018 ± 0.086, p = 0.007), with a lower incidence of physiological restenosis and MACCEs (2.1 vs. 8.4%, p = 0.018, 5.4 vs. 12.6%, p = 0.021, respectively).Conclusion: Evaluated by QFR, patients who achieved the LDL-C goal appear to have a better coronary physiological benefit. This group of patients also has a better clinical outcome. |
topic |
percutaneous coronary intervention LDL—cholesterol quantative flow ratio cornoray physiology physiological restenosis |
url |
https://www.frontiersin.org/articles/10.3389/fcvm.2021.679599/full |
work_keys_str_mv |
AT longchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT longchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT longchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT qinchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT qinchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT qinchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT jiaxinzhong effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT jiaxinzhong effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT jiaxinzhong effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT zhenye effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT zhenye effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT zhenye effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT mingfangye effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT mingfangye effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT mingfangye effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT yuanmingyan effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT yuanmingyan effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT yuanmingyan effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT lianglongchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT lianglongchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT lianglongchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT yukunluo effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT yukunluo effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention AT yukunluo effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention |
_version_ |
1721373344752730112 |